# Stereotactic Body Radiotherapy for Osseous Low Alpha-Beta Resistant Metastases for Pain Relief

> **NCT04177056** · NA · UNKNOWN · sponsor: **Hamilton Health Sciences Corporation** · enrollment: 40 (estimated)

## Conditions studied

- Bone Metastases
- Prostate Cancer
- Breast Cancer
- Renal Cell Carcinoma
- Melanoma

## Interventions

- **RADIATION:** SBRT

## Key facts

- **NCT ID:** NCT04177056
- **Lead sponsor:** Hamilton Health Sciences Corporation
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-12-04
- **Primary completion:** 2022-03-01
- **Final completion:** 2023-01-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2021-08-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04177056

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04177056, "Stereotactic Body Radiotherapy for Osseous Low Alpha-Beta Resistant Metastases for Pain Relief". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04177056. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*